Be part of something altogether life-changing!

Working at Cytiva means being at the forefront of providing new solutions to transform human health. Our incredible customers undertake life-saving activities ranging from fundamental biological research to developing innovative vaccines, new medicines, and cell and gene therapies.

At Cytiva you will be able to continuously improve yourself and us – working on challenges that truly matter with people that care for each other, our customers, and their patients. With associates across 40+ countries, Cytiva is a place where every day is a learning opportunity – so you can grow your career and expand your skills in the long term.

Forming part of the Biotechnology segment at Danaher, we bring together dedicated technical expertise and talent to develop the next generation of life-changing therapeutics.

The Director, Scientific Office for Genomic Medicine is a scientifically credible, externally facing leader who shapes Cytiva’s innovation agenda in genomic medicine. With a deep understanding of emerging technologies, customer needs, and scientific trends across viral vectors and cell and gene therapy, this role sets and drives Cytiva’s technology vision, strengthens external scientific presence, and serves as a senior expert across genomics, cell therapy, and gene therapy.

Acting as a bridge between science, strategy, and execution, the Director partners closely with R&D, Commercial, Marketing, Product Management, Regulatory, Manufacturing, and BD to translate insights into differentiated innovation, next‑generation products, and strategic collaborations that reinforce Cytiva’s leadership in genomic medicine.

This position is part of the Scientific Office within the Genomic Medicine business located in Germany and will be an on-site role. At Cytiva, our vision is, to advance future therapeutics from discovery to delivery.

In this role, you will have the opportunity to:

• Shape Cytiva’s scientific and technology vision for genomic medicine, guiding innovation strategy and next‑generation product roadmaps across viral vector and CGT technologies.

• Lead early‑stage innovation scouting by identifying emerging science, platforms, and disruptive technologies that inform future product and platform evolution.

• Serve as Cytiva’s external scientific ambassador, representing the company at key conferences, advisory boards, and scientific networks to strengthen visibility and influence.

• Build and nurture strategic collaborations with academia, biotech, and ecosystem partners to accelerate scientific leadership and technology development, ensuring business impact.

• Provide scientific expertise across genomics, viral vectors, cell therapy, and gene therapy to guide R&D, commercial, BD, and strategic teams.

• Translate customer and market insights into clear internal guidance, identifying unmet needs, technology trends, and business opportunities to shape portfolio and partnership decisions.

• Drive cross‑functional alignment across R&D, manufacturing, marketing, regulatory, and commercial functions to ensure cohesive and market‑backed technology execution.

• Deliver scientific communication and thought leadership, influencing executive decision‑making and elevating Cytiva’s profile through publications, presentations, and digital content.

The essential requirements of the job include:

• PhD (preferred) or Master’s degree in Molecular Biology, Virology, Genetics, Cell Biology, Biomedical Engineering, or a closely related life‑science field.

• 10+ years of experience in biopharma, biotechnology, or the cell & gene therapy/viral vector ecosystem, including exposure to innovation, R&D, or advanced technologies.

• Deep scientific expertise in viral vectors (AAV, LV, viruses) and cell therapy platforms, with strong understanding of upstream, downstream, and analytical workflows.

• Demonstrated experience with early‑stage innovation, technology scouting, or evaluating emerging scientific/technical trends relevant to genomic medicine.

• Familiarity with industry‑standard scientific tools and systems, such as ELNs/LIMS, sequence/design platforms (e.g., SnapGene, Benchling), and data analysis tools (e.g., Prism, JMP).

• Cross‑functional R&D or product development exposure, ideally collaborating with Manufacturing, Commercial, Regulatory, and Business Development teams on scientific or technical programs.

• Proven experience interfacing with external scientific ecosystems, including academic groups, biotech innovators, consortia, or technology/industry forums.

Join our winning team today. Together, we’ll accelerate the real-life impact of tomorrow’s science and technology. We partner with customers across the globe to help them solve their most complex challenges, architecting solutions that bring the power of science to life.

For more information, visit www.danaher.com.